Medtronic Stock: Analysts See Upside Despite Market Underperformance
While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
ASML Holding NV has launched a massive new share repurchase program and reaffirmed strong sales guidance, as record AI-related equipment orders fuel optimism about the Dutch tech giant's central role in the semiconductor industry's future.
Coinbase stock fell over 2% as a broad cryptocurrency sell-off dragged Bitcoin to a 10-month low. The decline was exacerbated by sustained net withdrawals from Spot Bitcoin ETFs, indicating shifting institutional sentiment.
The U.S. manufacturing sector snapped a year-long contraction in January, with the PMI surging to its highest level since early 2022. A sharp rebound in new orders and production fueled the expansion, though concerns over future tariff policies and a still-sluggish jobs market temper the optimism.
U.S. stocks opened higher Monday, reversing earlier futures losses, as a stronger-than-expected manufacturing report boosted sentiment. The Dow Jones and Russell 2000 led the gains.
While the energy sector retrenched amid falling crude prices, ExxonMobil executed a massive $20 billion share repurchase program in 2025, underlining its financial muscle and commitment to shareholder returns. The oil giant also reported earnings that beat estimates, driven by record production in the Permian Basin and Guyana, even as it takes a hardline stance on reinvesting in Venezuela.
Chinese regulators have greenlit the first wave of Nvidia's advanced H200 AI chip orders for major firms including Alibaba and ByteDance, marking a potential turning point for the chipmaker's access to a critical market and fueling optimism for its stock trajectory.
While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.
Amidst a resilient market backdrop, we spotlight three U.S. stocks trading significantly below their estimated intrinsic value, offering potential for investors willing to navigate current volatility.
Amid a backdrop of cautious market optimism, companies with significant insider ownership are drawing investor attention. We examine three firms where those closest to the business are putting their money, spanning biotech, advanced semiconductors, and regional banking.
In a stark episode of his show, personal finance expert Dave Ramsey labeled a husband's control over family finances as '100% abusive.' The case highlights how economic manipulation traps victims, a pattern experts say underpins nearly all domestic violence.
NuScale Power's stock has surged over 640% since early 2024, fueled by investor optimism around its small modular reactor technology. While the potential is vast, analysts caution the road ahead remains fraught with financial and regulatory challenges.
The United Arab Emirates has achieved a milestone in its economic transformation, with non-oil trade exceeding $1 trillion for the first time in 2025. This rapid growth is closing the export gap with regional heavyweight Saudi Arabia, as both Gulf states accelerate their push beyond hydrocarbons.
A synchronized selloff on January 30, 2026, saw Bitcoin and key industrial metals like copper plunge together, underscoring Bitcoin's evolving role as a barometer for global economic sentiment rather than a digital safe haven.
A critical week ahead for crypto markets as major corporate earnings coincide with key U.S. employment data, setting the tone for digital asset sentiment amidst a shifting macroeconomic landscape.
Despite lagging the broader market over the past year, fertilizer giant Mosaic is showing signs of a rebound in 2026. Analysts maintain a cautiously optimistic 'Moderate Buy' stance, eyeing a potential recovery in crop nutrient demand.
While Disney's latest earnings surpassed expectations, investor focus shifted sharply to reports of an accelerated CEO succession timeline, sending the stock lower despite robust performance in streaming and theme parks.
Despite a significant lag behind the broader market over the past year, analysts maintain a cautiously optimistic stance on Copart's long-term prospects, even as near-term headwinds persist.
Despite a recent earnings miss, Charles Schwab's stock has significantly outpaced the market over the past year. Wall Street maintains a cautiously optimistic stance, with upgraded ratings and bullish price targets pointing to further potential gains.
As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.